439 related articles for article (PubMed ID: 36845095)
1. The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression.
Li M; Jiang P; Wei S; Wang J; Li C
Front Immunol; 2023; 14():1113312. PubMed ID: 36845095
[TBL] [Abstract][Full Text] [Related]
2. Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.
Curtis LT; Sebens S; Frieboes HB
Cancer Immunol Immunother; 2021 May; 70(5):1475-1488. PubMed ID: 33180183
[TBL] [Abstract][Full Text] [Related]
3. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
[TBL] [Abstract][Full Text] [Related]
5. Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules.
Zhou G; Sprengers D; Mancham S; Erkens R; Boor PPC; van Beek AA; Doukas M; Noordam L; Campos Carrascosa L; de Ruiter V; van Leeuwen RWF; Polak WG; de Jonge J; Groot Koerkamp B; van Rosmalen B; van Gulik TM; Verheij J; IJzermans JNM; Bruno MJ; Kwekkeboom J
J Hepatol; 2019 Oct; 71(4):753-762. PubMed ID: 31195061
[TBL] [Abstract][Full Text] [Related]
6. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.
Cheruku S; Rao V; Pandey R; Rao Chamallamudi M; Velayutham R; Kumar N
Int Immunopharmacol; 2023 Mar; 116():109569. PubMed ID: 36773572
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity.
Harrell CR; Volarevic A; Djonov VG; Jovicic N; Volarevic V
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830312
[TBL] [Abstract][Full Text] [Related]
9. Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation.
Kim EK; Yoon SO; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
Gastric Cancer; 2017 May; 20(3):438-447. PubMed ID: 27318497
[TBL] [Abstract][Full Text] [Related]
10. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
[TBL] [Abstract][Full Text] [Related]
11. The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and Repression.
Pernot S; Evrard S; Khatib AM
Front Immunol; 2022; 13():850856. PubMed ID: 35493456
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between IL-15Rα
Zhang W; Zhang Q; Yang N; Shi Q; Su H; Lin T; He Z; Wang W; Guo H; Shen P
Cancer Commun (Lond); 2022 Jun; 42(6):536-557. PubMed ID: 35615815
[TBL] [Abstract][Full Text] [Related]
13. Immune cell networking in solid tumors: focus on macrophages and neutrophils.
Di Ceglie I; Carnevale S; Rigatelli A; Grieco G; Molisso P; Jaillon S
Front Immunol; 2024; 15():1341390. PubMed ID: 38426089
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
15. Effects of CSF1R-targeted chimeric antigen receptor-modified NK92MI & T cells on tumor-associated macrophages.
Zhang P; Zhao S; Wu C; Li J; Li Z; Wen C; Hu S; An G; Meng H; Zhang X; Yang L
Immunotherapy; 2018 Aug; 10(11):935-949. PubMed ID: 30149762
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between macrophages and natural killer cells in the tumor microenvironment.
Zhou J; Zhang S; Guo C
Int Immunopharmacol; 2021 Dec; 101(Pt B):108374. PubMed ID: 34824036
[TBL] [Abstract][Full Text] [Related]
17. Immune Landscape of Thyroid Cancers: New Insights.
Menicali E; Guzzetti M; Morelli S; Moretti S; Puxeddu E
Front Endocrinol (Lausanne); 2020; 11():637826. PubMed ID: 33986723
[TBL] [Abstract][Full Text] [Related]
18. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
19. Neutrophils in cancer: dual roles through intercellular interactions.
Yu X; Li C; Wang Z; Xu Y; Shao S; Shao F; Wang H; Liu J
Oncogene; 2024 Apr; 43(16):1163-1177. PubMed ID: 38472320
[TBL] [Abstract][Full Text] [Related]
20. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
Qu X; Tang Y; Hua S
Front Immunol; 2018; 9():563. PubMed ID: 29662489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
